2Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis, 1998,17:73-77. 被引量：1
3Afzal-Shah M, Livermore DM. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother, 1998,41:576-577. 被引量：1
4Seifert H, Gerner-Smidt P. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J Clin Microbiol, 1995,33 : 1402-1407. 被引量：1
5Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis:criteria for bacterial strain typing. J Clin Microbiol,1995,33:2233-2239. 被引量：1
6Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 2001,45 :583-588. 被引量：1
7Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents, 2003,21:58-62. 被引量：1
8Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect, 2002,8:321-331. 被引量：1
9Donald HM, Scaife W, Amyes SG. et al. Sequence analysis of ARI-1, a novel OXA beta -lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother,2000,44:196-199. 被引量：1
10Thal L, Donabedian S, Robinson-DunBny B, et al. Molecular analysis of glycopeptide resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period. J Clin Microbiol, 1998,36:3303-3308. 被引量：1
6Ozkurt Z, Ertek M, Erol S, et al. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit [J]. Bums, 2005,31(7) :870-873. 被引量：1
7Murray P R, Baron E J, Jorgensen J H, et al. Manual of Clinical Microbiology[M]. 8th ed. Washington DC, USA: ASMPress, 2003: 185 - 207. 被引量：1
8National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 9th information supplement [ C ]. Wayne, Pa : NCCLS, 2002. 被引量：1
9Garner J S, Jarvis W R, Emori T G, et al. CDC definitions for nosocomial infections[J]. Am J Infect Control, 1988, 16(3) : 128 -140. 被引量：1
10Drannik A G, Pouladi M A, Robbins C S, et aL Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection[J]. Am J Respir Crit Care Meal, 2004, 170( 11 ): 1164 - 1171. 被引量：1
